# Pfizer Inc. (PFE) — Q3-2018 Earnings Results

**Report date:** 2018-10-30 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q3-2018

## Post-Earnings Brief

### Headline

Pfizer Misses on EPS, Stock Down 0.79%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.78 | N/A | -0.21% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management acknowledged the competitive landscape while expressing confidence in their future product pipeline. They did not provide specific guidance for the upcoming quarters.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized a focus on innovation and pipeline development.

### Guidance Changes

No guidance data was provided in this earnings report.

### What It Means

Pfizer's earnings report showed a slight miss on EPS, which contributed to a 0.79% decline in stock price. The lack of revenue data and guidance may have raised concerns among investors about the company's future performance. Management's cautious tone suggests they are aware of market challenges but remain focused on their product development efforts.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q3-2018_